Unmet needs in pediatric NAFLD research: what do we need to prioritize for the future?

Diagnostic and therapeutic challenges for dermatologists: What shall we do when we don’t know what to do?

What shall we do when we have done everything we could for the diagnosis and treatment of a patient, but were not successful? What shall we do when there is no definite treatment for a patient? What shall we do when we have no diagnosis or treatment for a patient? Some useful suggestions are presented here to get rid of these situations.

What do we know? What do we need to know?

Do We Know What We Do not Know? A Response to Celine Bonnet

Molecular approaches to diagnosis of invasive aspergillosis what we know and what we do not know.

Invasive aspergillosis (IA) are a major complication in immunocompromized patients where can be serious and rapidly fatal. Early diagnosis and early appropriate antifungal treatment is important in reducing mortality and morbidity. But despite many efforts to develop detection methods, the diagnosis of IA still remains challenging and current conventional methods are limited for adequate diagno...

What do we need to do to tackle antimicrobial resistance?

Infectious disease accounts for a substantial proportion of deaths worldwide. Continuing progress in the treatment of many infections is now threatened by the increasing numbers and widening distribution of pathogens resistant to antimicrobial (antibacterial, antiviral, antiparasitic, and antifungal) drugs. Until fairly recently, antimicrobial resistance was regarded as an issue mainly confi ne...